All Type of News
Bill to prevent doctor’s over-prescription hits snag
The National Assembly’s Health, Welfare and Family Affairs Committee rejected on November 12 a bill to get overcharged medication costs for outpatients refunded to the National Health Insurance Corporation.
The maj...
Dong-A ships first batch of Zydena to RussiaDong-A Pharmaceutical Co., Korea's largest pharmaceutical company, said on December 12 that it has started shipping 135,000 tablets of Zydena, an erectile dysfunction drug, to ...
|
KFDA-certified drug logistics center opensA new drug logistics center opens, called Jamyung, has recently stated its operation in Cholla Province.
The 9.2 billion won center was first certified by the Korea Food and ...
|
Chong Kun Dang release Penzal seriesChong Kun Dang Pharmaceutical has put out a series of Penzal in the form of tablet and drink, a popular antipyretic and anti-inflammatory agent.
The newly released Penzal-Q a...
|
Donwha receives presidential award for DW-1350Dongwha Pharm said on November 11 that following DW224a (zabofloxacin), it received, for the consecutive two years, the Presidential Award in 2008 Health Industry and Technology...
|
RMS Korea likely to take over leading wholesaling firms
Rumors are spreading that RMS Korea will acquire several wholesaling firms with 100 billion in sales throughout the countries, in an effort to expand its presence in the domestic wholesaling industry.
Sources say w...
Manufacture of 400 items to be suspended
The Korea Food and Drug Administration says it will soon mete out administrative dispositions over 400 drugs that were found not to observe the small package regulation.
The punitive action was inevitable as 60 pha...
Korea’s efforts for self-purification attract IFPMA members
The Korean pharmaceutical firms’ launching of a compliance program (CP) for fair trade, together with efforts for self-purification to root out illicit practices, draw keen interest from members of the International F...
Korea’s GMP rating shows signs of improvement
The GMP rating for Korean pharmaceutical firms is seeing signs of improvement.
The Korea Food and Drug Administration said that a total of 59 pharmaceutical manufacturers were rated over “C” class.
The current ...
Viromed conducts phase I clinical trial for VM202 in China
The phase I clinical trial with VM202, a gene-based medicine for treatment of cardiovascular disease (CVD), has been conducted by ViroMed’s China partner Beijing Northland Biotech for peripheral artery disease (PAD, a...
